GURUFOCUS.COM » STOCK LIST » USA » NAS » Lantheus Holdings Inc (NAS:LNTH) » Definitions » Financial Strength
Switch to:

Lantheus Holdings Financial Strength

: 6 (As of Jun. 2022)
View and export this data going back to 2015. Start your Free Trial

Lantheus Holdings has the Financial Strength Rank of 6.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Lantheus Holdings's Interest Coverage for the quarter that ended in Jun. 2022 was 43.03. Lantheus Holdings's debt to revenue ratio for the quarter that ended in Jun. 2022 was 0.21. As of today, Lantheus Holdings's Altman Z-Score is 8.22.


Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Lantheus Holdings Financial Strength Distribution

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Financial Strength distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Financial Strength falls into.



Lantheus Holdings Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Lantheus Holdings's Interest Expense for the months ended in Jun. 2022 was $-1.5 Mil. Its Operating Income for the months ended in Jun. 2022 was $63.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $171.4 Mil.

Lantheus Holdings's Interest Coverage for the quarter that ended in Jun. 2022 is

Interest Coverage=-1*Operating Income (Q: Jun. 2022 )/Interest Expense (Q: Jun. 2022 )
=-1*63.204/-1.469
=43.03

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Lantheus Holdings's Debt to Revenue Ratio for the quarter that ended in Jun. 2022 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2022 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(14.065 + 171.444) / 894.892
=0.21

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Lantheus Holdings has a Z-score of 8.22, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 8.22 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lantheus Holdings  (NAS:LNTH) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Lantheus Holdings has the Financial Strength Rank of 6.


Lantheus Holdings Financial Strength Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings Business Description

Lantheus Holdings logo
Traded in Other Exchanges
Address
331 Treble Cove Road, North Billerica, MA, USA, 01862
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.
Executives
Baylor-henry Minnie director C/O SCPHARMACUETICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Yao Ying Vivian officer: Chief Human Resources Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Sabens Andrea officer: Chief Accounting Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Walker Carol officer: Senior Vice President, Quality C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Montagut Etienne officer: See Remarks C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Niedzwiecki Daniel officer: See Remarks C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Maeusli Heinz Christoph director SCHUETZENWEG 3 ENGELBURG V8 9032
Ber Gerard director C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Blanchfield Paul officer: Chief Commercial Officer C/O LANTHEUS HOLDINGS, INC. 331 NORTH BILLERICA MA 01862
Molnar Istvan officer: Chief Medical Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Marshall Robert J. Jr. officer: CFO and Treasurer C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Bolla John J. director C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Pucel Kenneth director 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234
Thrall James H director 343 COMMERCIAL STREET #314 BOSTON MA 02109
Pruden Gary J director ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Lantheus Holdings Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)